Secondary alterations of sphingolipid metabolism in lysosomal storage diseases. - Wikidata - awgldk - TriplyDB

Secondary alterations of sphingolipid metabolism in lysosomal storage diseases.

Secondary alterations of sphingolipid metabolism in lysosomal storage diseases.

http://www.wikidata.org/entity/Q37826106

about

The cell biology of disease: lysosomal storage disorders: the cellular impact of lysosomal dysfunction Impairment of homeostasis in lysosomal storage disorders Cathepsin B overexpression due to acid sphingomyelinase ablation promotes liver fibrosis in Niemann-Pick disease.ASMase is required for chronic alcohol induced hepatic endoplasmic reticulum stress and mitochondrial cholesterol loading.Port-to-port delivery: Mobilization of toxic sphingolipids via extracellular vesicles.Mucopolysaccharidosis type I: current knowledge on its pathophysiological mechanisms.Pharmaceutical Chaperones and Proteostasis Regulators in the Therapy of Lysosomal Storage Disorders: Current Perspective and Future Promises.ASMase regulates autophagy and lysosomal membrane permeabilization and its inhibition prevents early stage non-alcoholic steatohepatitis.Sensorimotor and Neurocognitive Dysfunctions Parallel Early Telencephalic Neuropathology in Fucosidosis Mice.

P2860

Q24603159-EC1F50C9-D823-47F5-898E-A97B4502637C Q26864999-65B687E3-CA97-40C9-9E13-10E735BBBE7C Q35668715-C6F51ADC-A7DF-4FD9-A834-995AB8FEA2E3 Q37188851-4C39DD87-EA97-40C4-AA9B-E7A00A65C2D9 Q37265491-7A8DD123-4FA6-4668-A5B5-A64BA67950F2 Q38004963-55013658-D6F3-4C69-B00A-2F05BBF99162 Q38652950-D66C794B-CC5C-403F-AF36-B6CF817117B9 Q41921041-0CD24D85-5290-41C0-813A-EFA42311E6DA Q52692069-9539A7B5-D909-498C-A64C-E2E5E2FB10C3

P2860

Secondary alterations of sphingolipid metabolism in lysosomal storage diseases.

http://www.wikidata.org/entity/Q37826106

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 05 January 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Secondary alterations of sphingolipid metabolism in lysosomal storage diseases.

@en

Secondary alterations of sphingolipid metabolism in lysosomal storage diseases.

@nl

type

label

Secondary alterations of sphingolipid metabolism in lysosomal storage diseases.

@en

Secondary alterations of sphingolipid metabolism in lysosomal storage diseases.

@nl

prefLabel

Secondary alterations of sphingolipid metabolism in lysosomal storage diseases.

@en

Secondary alterations of sphingolipid metabolism in lysosomal storage diseases.

@nl

P1433

Q37826106-A7127150-7FD9-4525-AB5F-893FF5D32B3C

P1476

Q37826106-8B9B508F-C7C1-4229-AEAB-EAB7113FF294

P2093

Q37826106-2BDCF0F5-69E7-44F9-B37C-47CAABF94D9C

Q37826106-8BF216F6-F63B-4B0D-A303-B31F48A879FE

Q37826106-A4FEEE75-AAAD-4304-A793-287B9D8AECAD

P2860

Q37826106-02512C93-7008-440C-A26A-E4592707312C

Q37826106-02A02CD2-456F-4DA8-9C32-9D55F5A07436

Q37826106-055E9078-7D5C-4F87-A4F6-2E52E211C2FF

Q37826106-05CCEF47-E0CF-4CC3-B6C8-FB9A5C436436

Q37826106-0AA579BF-E858-4344-97A1-58627195435F

Q37826106-10881598-7CFD-4853-B164-5D31842196C5

Q37826106-1352EB3D-3D37-4BEE-B8D5-43DBDC82B3FE

Q37826106-14CCFE45-15A4-4555-B72D-E183677A1256

Q37826106-18CB3413-38F7-462F-BBFD-193A8E88A7B0

Q37826106-19FA4BBE-11E5-46F3-A3E3-592C2292A352

P2888

Q37826106-0005FAEC-C304-4538-B862-A970D7887B51

P304

Q37826106-CC11D434-2782-4E7D-A152-F7D3A8107977

P31

Q37826106-4CDF83E0-6784-4F7C-BAF0-9DE508A800BD

Q37826106-9f4c7435-97bf-4012-b34a-01e8cb6987ee

P356

Q37826106-73E62786-7784-4018-9CD1-FC51A6C98301

P433

Q37826106-CA15FC59-6B53-4A6A-B261-4346457E4586

P478

Q37826106-91736199-B93A-4AD4-AA17-C7DC0130F394

P50

Q37826106-2A08A09B-5306-4A4A-9CEA-3BBD14B4969D

Q37826106-BCA198DF-8934-4023-8A64-EC5ADDADDD2C

Q37826106-F9DA37B3-1C3B-45FB-9BE9-793C925D34CC

P577

Q37826106-7D6087A9-13D1-44C7-8B4F-6A4F8EAB79DB

P698

Q37826106-5D5C3432-861D-42E0-8B81-EC8E773B929C

P356

S11064-010-0380-3

P1433

Neurochemical Research

P1476

Secondary alterations of sphingolipid metabolism in lysosomal storage diseases

@en

P2093

Edward H Schuchman

http://www.w3.org/2001/XMLSchema#string

Simona Prioni

http://www.w3.org/2001/XMLSchema#string

Vanna Chigorno

http://www.w3.org/2001/XMLSchema#string

P2860

Acid sphingomyelinase deficient mice: a model of types A and B Niemann-Pick disease

Correction of mucopolysaccharidosis type IIIb fibroblasts by lentiviral vector-mediated gene transfer

Prevention of lysosomal storage in Tay-Sachs mice treated with N-butyldeoxynojirimycin

Involvement of gangliosides in glycosylphosphatidylinositol-anchored neuronal cell adhesion molecule TAG-1 signaling in lipid rafts

Lipid rafts as a membrane-organizing principle

Inhibition of sphingolipid synthesis affects kinetics but not fidelity of L1/NgCAM transport along direct but not transcytotic axonal pathways.

Effective gene therapy in an authentic model of Tay-Sachs-related diseases

Adult ceramide synthase 2 (CERS2)-deficient mice exhibit myelin sheath defects, cerebellar degeneration, and hepatocarcinomas.

A vital role for glycosphingolipid synthesis during development and differentiation

Neurons in Niemann-Pick disease type C accumulate gangliosides as well as unesterified cholesterol and undergo dendritic and axonal alterations.

P2888

s11064-010-0380-3

P304

1654-1668

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11064-010-0380-3

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

36

http://www.w3.org/2001/XMLSchema#string

P50

Alessandro Prinetti

Elena Chiricozzi

P577

2011-01-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21207141

http://www.w3.org/2001/XMLSchema#string